Literature DB >> 25130168

Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC).

Fei Ma1, Huihui Li2, Haijuan Wang3, Xiuqing Shi1, Ying Fan1, Xiaoyan Ding1, Chen Lin3, Qimin Zhan3, Haili Qian4, Binghe Xu5.   

Abstract

The mechanism underlying the aggressive behaviors of triple negative breast cancer (TNBC) is not well characterized yet. The association between cancer stem cell (CSC) population and the aggressive behaviors of TNBC has not been established. We found the CD44(+)/CD24(-) cell population was enriched in TNBC tissues and cell lines, with a higher capacity of proliferation, migration, invasion and tumorigenicity as well as lower adhesion ability. The CD44(+)/CD24(-) cell population with cancer stem cell-like properties may play an important role in the aggressive behaviors of TNBC. This discovery may lead to new therapeutic strategies targeting CD44(+)/CD24(-) cell population in TNBC.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CD44(+)/CD24(−).; Cancer stem cells; Triple negative breast cancer

Mesh:

Substances:

Year:  2014        PMID: 25130168     DOI: 10.1016/j.canlet.2014.06.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  50 in total

Review 1.  Prevention of breast cancer by dietary polyphenols-role of cancer stem cells.

Authors:  Hao-Feng Gu; Xue-Ying Mao; Min Du
Journal:  Crit Rev Food Sci Nutr       Date:  2019-01-11       Impact factor: 11.176

2.  Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors.

Authors:  Stephanie L Ham; Ramila Joshi; Gary D Luker; Hossein Tavana
Journal:  Adv Healthc Mater       Date:  2016-09-07       Impact factor: 9.933

3.  TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.

Authors:  Tiara T Byrd; Kristen Fousek; Antonella Pignata; Christopher Szot; Heba Samaha; Steven Seaman; Lacey Dobrolecki; Vita S Salsman; Htoo Zarni Oo; Kevin Bielamowicz; Daniel Landi; Nino Rainusso; John Hicks; Suzanne Powell; Matthew L Baker; Winfried S Wels; Joachim Koch; Poul H Sorensen; Benjamin Deneen; Matthew J Ellis; Michael T Lewis; Meenakshi Hegde; Bradley S Fletcher; Brad St Croix; Nabil Ahmed
Journal:  Cancer Res       Date:  2017-11-28       Impact factor: 12.701

4.  Acidification of Tumor at Stromal Boundaries Drives Transcriptome Alterations Associated with Aggressive Phenotypes.

Authors:  Nazanin Rohani; Liangliang Hao; Maria S Alexis; Brian A Joughin; Konstantin Krismer; Mira N Moufarrej; Anthony R Soltis; Douglas A Lauffenburger; Michael B Yaffe; Christopher B Burge; Sangeeta N Bhatia; Frank B Gertler
Journal:  Cancer Res       Date:  2019-02-12       Impact factor: 12.701

5.  SLFN12 Over-expression Sensitizes Triple Negative Breast Cancer Cells to Chemotherapy Drugs and Radiotherapy.

Authors:  Ahmed Adham Raafat Elsayed; Sarmad Al-Marsoummi; Emilie E Vomhof-Dekrey; Marc D Basson
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

6.  Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells.

Authors:  Sylvia S Gayle; Jennifer M Sahni; Bryan M Webb; Kristen L Weber-Bonk; Melyssa S Shively; Raffaella Spina; Eli E Bar; Mathew K Summers; Ruth A Keri
Journal:  J Biol Chem       Date:  2018-11-27       Impact factor: 5.157

7.  KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer.

Authors:  Mei Zhou; Prabhakar Pitta Venkata; Suryavathi Viswanadhapalli; Bridgitte Palacios; Salvador Alejo; Yihong Chen; Yi He; Uday P Pratap; Junhao Liu; Yi Zou; Zhao Lai; Takayoshi Suzuki; Andrew J Brenner; Rajeshwar R Tekmal; Ratna K Vadlamudi; Gangadhara R Sareddy
Journal:  Breast Cancer Res Treat       Date:  2020-10-14       Impact factor: 4.872

8.  Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.

Authors:  Sarmad Al-Marsoummi; Emilie Vomhof-DeKrey; Marc D Basson
Journal:  Cell Physiol Biochem       Date:  2019

9.  Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.

Authors:  Chang-Ching Lin; Miao-Chia Lo; Rebecca Moody; Hui Jiang; Ramdane Harouaka; Nicholas Stevers; Samantha Tinsley; Mari Gasparyan; Max Wicha; Duxin Sun
Journal:  Cancer Lett       Date:  2018-09-15       Impact factor: 8.679

Review 10.  Progress of Breast Cancer basic research in China.

Authors:  Xuerong Wang; Chao Wang; Jiaheng Guan; Baoan Chen; Lin Xu; Ceshi Chen
Journal:  Int J Biol Sci       Date:  2021-05-11       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.